VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,314,727 | +24.7% | 1,565,209 | +28.5% | 0.01% | +20.0% |
| Q1 2023 | $8,268,977 | +244979.3% | 1,217,817 | +166.7% | 0.01% | +100.0% |
| Q4 2022 | $3,374 | -99.9% | 456,617 | +33.1% | 0.01% | 0.0% |
| Q3 2022 | $3,389,000 | +9.3% | 342,990 | +20.6% | 0.01% | +25.0% |
| Q2 2022 | $3,100,000 | +25.1% | 284,389 | +29.8% | 0.00% | +33.3% |
| Q1 2022 | $2,479,000 | -27.9% | 219,182 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,439,000 | -19.0% | 219,182 | -11.5% | 0.00% | -40.0% |
| Q3 2021 | $4,244,000 | – | 247,636 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |